3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Myelodysplastic Syndromes
11
Leukemia, Myeloid, Acute
8
Myeloproliferative Disorders
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Polycythemia Vera
3
Lymphoma, Non-Hodgkin
3
Leukemia
3
Thrombosis
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Leukemia, Myeloid, Accelerated Phase
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Blast Crisis
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urticaria Pigmentosa
1
Thrombocythemia, Essential
1
Pyruvate Kinase Deficiency of Red Cells
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Multiple Myeloma
1
Mastocytosis, Cutaneous
1
Lymphoproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Interventions
bemcentinib
1
Sodium Chloride
1
Blood Specimen Collection
1
BNT162 Vaccine
1
2019-nCoV Vaccine mRNA-1273
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
COVID-19
×
Blood Specimen Collection
×
Myeloid
×
Clear all
NCT04953312
2026-03-12
CALPRO
Assistance Publique - Hôpitaux de Paris
Phase NA
Withdrawn